| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.44 | 0.01 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.39 | 0.003 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.34 | 0.07 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |